I'm the regional manager of medication assistance for a health system. I've been in various pharmacy roles for 19 years but in medication assistance for over eight years.
What are some of your biggest challenges?
Medicare D/Advantage plan patients meeting the OOP spend
The Drug Companies having such high OOP spend requirements for these patients, that their access programs are still a barrier for patients
Medications you work with:
Oral, Infusion, Injectables
Which Manufacturers do you work with?
Novo Nordisk
Abbvie.
Boehringer Ingelheim
BMS
Abbvie.
Pfizer
GSK
Merck
Sanofi
Eli Lilly
What technology do you use to help you get your job done?
Internet, online database, EMR, fax, and email.
What do you hope to get out of the conference?
Instead of the Annual PAP conference where its Pharma's Regulatory teams discussing their legal jargon and policy, I want to see the maintenance medication manufacturers there listening to us, the advocates, explain our barriers, frustrations, pros, and cons when utilizing their companies.
Although the specialty drug companies are helpful, they aren't applicable to me and haven't been in the eight years I've attended these conferences. I want to hear from other community-based programs as well as hospital-based programs on how they operate their programs.
What are their obstacles and processes?
Who have they allied with to obtain information or streamline processes?
Do they meet with patients face-to-face or do they work behind the scenes?
Are there any specific medications you are referring to for maintenance?
No, I work with all of them.
Is there any very challenging programs you are dealing with in a certain therapeutic area that you would like to see at the conference, and which products?
The insulin programs are challenging the most, I'd say, due to their high OOP spend requirements.
Eli Lilly is $1,100, Novo Nordisk is $1,000,
Sanofi is 5% gross annual household income.
Other challenging ones: Entresto and J&J's 4% OOP requirement for Xarelto.
